Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07358949 · ClinicalTrials.gov registry record
Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i
A clinical trial, sponsored by Queen's Medical Center.
- Not yet
- Registry status
- 70
- Enrollment target
NCT07358949 is a clinical trial that has not yet begun recruiting, run by Queen's Medical Center. The registered enrollment target is 70 participants.
The verdict
NCT07358949 has not yet begun recruiting, sponsored by Queen's Medical Center.
- NOT YET RECRUITING
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of the study is to see if rapid syphilis testing at the time of a family planning (contraception or abortion) visit is acceptable and practical for patients. This study involves a fingerstick blood sample for syphilis testing during a family planning visit. Results will be ready in 10-15 minutes. Potential Benefits * Participants can find out whether they are syphilis positive or negative within the visit, as soon as 10-15 minutes of the finger stick. Typically, syphilis testing results take several days. * If positive, there is the option of starting treatment within the same day. Potential Risks * The study team will do everything possible to protect participants' privacy, including removing names and other identifiable information from study materials, however this is still a small chance there may be a breach of privacy during the study. * Physical risks of fingerstick are exceptionally rare when sterile technique is used. The study team will be using all best practices to reduce risk of infection or injury. * There is a risk of discomfort or pain with fingerstick collection. The risk of scarring is usually only associated with repeat draws, for example in patients with diabetes who have to do fingerstick draws multiple times per day. * There is a very small chance that the positive result is incorrect (also known as a "false positive"), meaning the participant does not actually have syphilis. To confirm the result, the investigators recommend that any positive rapid syphilis result be followed up with a blood test at the lab. Cost for Participation o There is no direct cost to participate in this study. After consent is signed, the participant received renumeration of $50 in form of gift card. If the participant tests positive for a syphilis infection, the participant or their health insurance will be responsible cover the costs of this medical treatment. If they do not have access to health insurance, the study team will connect the particip
Interventions
- DIAGNOSTIC_TEST Rapid Syphilis Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07358949
The ClinicalTrials.gov registry entry for NCT07358949 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Queen's Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapid Syphilis Test is the first listed.
NCT07358949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07358949 about?
NCT07358949 is a clinical study titled "Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i". The purpose of the study is to see if rapid syphilis testing at the time of a family planning (contraception or abortion) visit is acceptable and practical for patients. This study involves a fingerstick blood sample for syphilis testing during a family planning visit. Results will be ready in 10-1...
What is the current status of trial NCT07358949?
This trial is currently not yet recruiting. The enrollment target is 70 participants. The study started on 2026-03-30. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07358949?
The interventions under investigation include: Rapid Syphilis Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07358949?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.